34ID

iShares iBonds Dec 2034 Term $ Corp UCITS ETF USD (Dist)

ETFs & Funds · USD · SIX

34IDETF

Price

$5.108

+0.36%

Cap

Earnings

30d Trend

-0.2%

34ID
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

4% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level15
Momentum56
Technical48
Fund Quality80
Cost Efficiency68

Raw weighted: 67×Macro 0.99 (1%)=66

RISK

15/100
90d Volatility
4.0%Low
ATR %
0.2%Low daily moves
Max Drawdown (1Y)
-3.0%Resilient

MOMENTUM

56/100
12-1M Momentum
+7.3%Uptrend
6-1M Momentum
+0.1%Flat
1M Return
-0.2%Stable

TECHNICAL

48/100
RSI (14)
52.4Neutral
Price vs SMA200
+0.6%Flat
MACD
+0.01Bullish momentum
Bollinger Band
55%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.143Noisy/choppy

FUND QUALITY

80/100
Replication
PhysicalHolds actual assets
Holdings
1,225 positionsHighly diversified
Domicile
Ireland (tax-efficient)15% US withholding tax
Yield
4.54% (Distributing)High income

COST EFFICIENCY

68/100
Expense Ratio
0.12%Low cost
Fund Size (AUM)
$131MSmall

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months41
3-12 months55
1-5+ years74

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate iShares iBonds Dec 2034 Term $ Corp UCITS ETF USD (Dist) at 66/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 85/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-0.2%

3 MONTHS

-1.4%

12 MONTHS

+7.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. low-risk profile and Fund Quality (80) are the primary strengths. Historical volatility is low at 4%. I classify this as a defensive holding — low volatility and high business quality provide portfolio ballast.

defensiveScore: 66/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.